These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 40652)

  • 1. The cardiovascular acitivity of ICI 118,587 a novel beta-adrenoceptor partial agonist [proceedings].
    Barlow JJ; Main BD; Moors JA; Nuttall A; Snow HM
    Br J Pharmacol; 1979 Nov; 67(3):412P. PubMed ID: 40652
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587.
    Pouleur H; Rousseau MF; Mengeot P; Veriter C; Vincent MF; Brasseur LA
    Eur Heart J; 1982 Dec; 3 Suppl D():123-7. PubMed ID: 6130945
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of beta 1-partial agonist(ICI 118-587) on plasma catecholamines level and hemodynamics during exercise in congestive heart failure].
    Sato H; Matsuyama T; Ozaki H; Fukushima M; Matsumoto M
    Kokyu To Junkan; 1984 Nov; 32(11):1159-62. PubMed ID: 6151727
    [No Abstract]   [Full Text] [Related]  

  • 4. Xamoterol, a beta1-adrenoceptor partial agonist: a new approach to heart failure. Proceedings of the 1st International Heart Failure. Interlaken, 1988.
    Barnett DB; Breckenridge A
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):1S-91S. PubMed ID: 2572249
    [No Abstract]   [Full Text] [Related]  

  • 5. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and coronary vasodilative properties of a selective and full beta 1-adrenoceptor agonist, T-0509, in comparison with isoproterenol in anesthesized dogs.
    Yamazaki J; Sugimoto T; Yabana H; Nagao T
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):209-15. PubMed ID: 7526052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocker SL 75212 in healthy volunteers [proceedings].
    Bianchetti G; Cadigan PJ; Gomeni R; Kilborn JR; London DR; Morselli PL; Pentecost BL
    Br J Clin Pharmacol; 1979 Oct; 8(4):403P. PubMed ID: 41555
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors.
    Armour JA
    Can J Cardiol; 1997 Mar; 13(3):277-84. PubMed ID: 9117916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.
    Johnsson G; Jordö L; Lundborg P; Rönn O; Welin-Fogelberg I; Wikstrand J
    Eur J Clin Pharmacol; 1978 May; 13(3):163-70. PubMed ID: 27371
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of the new beta-adrenoceptor blocker SL 75212 on the cardiovascular responses to insulin induced hypoglycaemia in man [proceedings].
    Kilborn JR; Morselli PL; Saunders J; Sönksen PH
    Br J Clin Pharmacol; 1979 Oct; 8(4):409P. PubMed ID: 41561
    [No Abstract]   [Full Text] [Related]  

  • 13. New series of aryloxypropanolamines with both human beta(3)-adrenoceptor agonistic activity and free radical scavenging properties.
    Aubriot S; Nicolle E; Lattier M; Morel C; Cao W; Daniel KW; Collins S; Leclerc G; Faure P
    Bioorg Med Chem Lett; 2002 Jan; 12(2):209-12. PubMed ID: 11755356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?
    McDevitt DG
    Drugs; 1983 Apr; 25(4):331-8. PubMed ID: 6133735
    [No Abstract]   [Full Text] [Related]  

  • 15. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
    Nuttall A; Snow HM
    Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blocking drugs: the relevance of intrinsic sympathomimetic activity.
    Louis WJ; McNeil JJ
    Br J Clin Pharmacol; 1982; 13(Suppl 2):317S-320S. PubMed ID: 6125183
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement by denopamine (TA-064) of pentobarbital-induced cardiac failure in the dog heart-lung preparation.
    Nunoki K; Goto T; Satoh K; Taira N
    Heart Vessels; 1985 Nov; 1(4):216-9. PubMed ID: 3831029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
    Tangø M; Carlsen JE; Trap-Jensen J
    Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs.
    Galiè N; Metalli M; Zannoli R; Binetti G; Branzi A; Magnani B
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):91-7. PubMed ID: 2577281
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.